Replies to post #97140 on Creative Medical Technology Holdings Inc (CELZ)

[docprep]

Minimal treatment associated adverse effects where observed related to short term bruising at the site of harvest or injection. No long-term adverse events were noted related to the intervention. Mean improvements in IIEF-5 score were 2 in the Caverstem 1.0 low dose group, 3 in the high dose Caverstem 1.0 group and 9 in the Caverstem 2.0 group. Furthermore, improvements peaked by 3 months and maintained at 6 months follow-up.

[rrao11]

Agreed! And i was going to do the same. But, this was Bull-Shit. Can’t put lipstick on this pig any more!